Riparian Pharmaceuticals is discovering therapeutics to reverse endothelial dysfunction and provide a new approach to vascular health.

Riparian Pharmaceuticals

Riparian Pharmaceuticals | 434 followers on LinkedIn. Discovering therapeutics to improve vascular health | Riparian Pharmaceuticals is an early stage biotechnology company employing innovative models of vascular pathophysiology to discover novel therapeutics

In nature, the riparian zone is a unique rich ecosystem created through the interaction of a river with its banks. In the human body, moving blood, or hemodynamics, similarly interacts with the walls of blood vessels generating unique biological activity. This very interaction, between hemodynamics and the vascular wall, is a critical and unexplored determinant of vascular health.

CEO, President, Co-founder at Riparian Pharmaceuticals

Will Adams

Principal Scientist at Riparian Pharmaceuticals

Rafael Gil, PhD

Research Associate at Riparian Pharmaceuticals

Alison Hebert

Viewport Meta

IPhone / Mobile Compatible

Euro

Google Font API

Content Delivery Network

Amazon

Organization Schema

Google Apps for Business

Microsoft Azure DNS

CEO, President, Co-Founder

Research Associate

Principal Scientist, in Vivo Pharmacology

Rafael Gil

Business Management

Terry Johnson

CEO, President & Co-Founder

Guillermo Garcia-Cardena

Co-Founder & Scientific Advisor

Biotechnology Companies With Fewer Than 50 Employees (Top 10K)

Northeastern US Early Stage Companies

Greater Boston Area Companies With Fewer Than 100 Employees (Top 10K)

United States Early Stage Companies With Fewer Than 100 Employees

Riparian Pharmaceuticals is an early stage biotechnology company employing innovative models of vascular pathophysiology to discover novel therapeutics. The company develops medical therapies designed to treat cardiovascular and inflammatory diseases. 

The company is based in Boston Massachusetts.

Viva Ventures Biotech Fund

Series A - Riparian Pharmaceuticals

JMCR Partners

Venture Round - Riparian Pharmaceuticals

Boston

Massachusetts

United States

North America

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 21, 2024 6:18 AM	6fce540a
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 21, 2024 6:18 AM	1d4c75a5
crunchbase trigger	general	Nov 21, 2024 6:18 AM	a10a9fea
crunchbase profile	general	Nov 21, 2024 7:24 AM	fd3bbbcb
li profile	general	Nov 21, 2024 6:18 AM	2a236c0b
translate crunchbase fundingrounds	general	Nov 21, 2024 7:40 AM	a350ccff
peers	general	Nov 21, 2024 6:18 AM	d4a8345a
news basic	general	Nov 21, 2024 6:18 AM	79860f38
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

RIPA

COM:RIPARIANPHARMA

Riparian Pharmaceuticals